Article information
Full Text
CLINICS 2010;65(12):1351-1356
Replace: Table 1
| Group | η | Infused substance | Infusion period | Posology |
|---|---|---|---|---|
| A1 (control) | 10 | SS 0.9% | Between the 5th and 40th POD | Twice a week |
| A2 (prophylaxis) | 10 | SCFA | Between the 5th and 40th POD | Twice a week |
| B1 (control) | 10 | SS 0.9% | After the 40th POD | Twice a day for 7 days |
| B2 (treatment) | 10 | SCFA | After the 40th POD | Twice a day for 7 days |
SS = saline solution. SCAF = short-chain fatty acids. POD = post-operatory day.
For:
CLINICS 2010;65(12):1399-1400Replace: RejaneMattar, Maria Monteiro para Maria do Socorro Monteiro, Joyce Matie Silva para Joyce Matie Kinoshita da Silva, FlairCarrilhopara Flair José Carrilho
For: Rejane Mattar, Maria do Socorro Monteiro, Joyce Matie Kinoshita da Silva, Flair José Carrilho
Copyright © 2011. CLINICS